Lymphoma  >>  Decadron (dexamethasone)  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Decadron (dexamethasone) / Merck (MSD)
NCT00187122: Treatment for Patients With Stage III or IV Non-Hodgkin Lymphoma

Completed
N/A
42
US
Vincristine, Oncovin®, Vincasar Pfs®, Radiation Therapy, Daunomycin, Cerubidine®, L-Asparaginase, Elspar®, Kidrolase®, Cytarabine, Cytosar-U®, Methotrexate, Rheumatrex®, TrexallTM, Mercaptopurine, Purinethol ®, Etoposide, Toposar®, VePesid®, Etopophos®, Cyclophosphamide, Cytoxan®, Neosar®, Prednisone, Deltasone®, Liquid Pred®, Meticorten®, Orasone®, Dexamethasone, Decadron, Diodex, Hexadrol, Maxidex
St. Jude Children's Research Hospital
Lymphoblastic Lymphoma
06/04
06/04
NCT00293384: Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant

Completed
N/A
40
US
Aprepitant, Emend, Cyclophosphamide, Cytoxan®, Neosar®, Dexamethasone, Decadron, Diodex, Hexadrol, Maxidex, Dexamethasone Sodium Phosphate, Dexamethasone Acetate, Granisetron hydrochloride, KYTRIL®
Barbara Ann Karmanos Cancer Institute, National Cancer Institute (NCI)
Breast Cancer, Chronic Myeloproliferative Disorders, Gestational Trophoblastic Tumor, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Nausea and Vomiting, Neuroblastoma, Ovarian Cancer, Testicular Germ Cell Tumor
06/09
02/12

Download Options